持股变动声明
Passage Bio(PASG)03-20 04:15
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008495 Size: 5 KB 网页链接
简介：Passage Bio, Inc.是一家位于特拉华州的公司，成立于2017年7月26日，是一家专注于开发罕见的单基因中枢神经系统疾病的转化疗法的基因药物公司。其愿景是成为领先的基因药物公司，并积极改变因为遭受这些疾病而受到生命威胁的患者生活。
| 今开：1.22 | 昨收：1.24 |
| 最高：1.26 | 最低：1.2 |
| 涨停价： | 跌停价： |
| 总市值：75166391 |
Passage Bio(PASG)03-20 04:15
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008495 Size: 5 KB 网页链接
Passage Bio(PASG)04-09 18:05
$Passage Bio(PASG)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-044912 Act: 34 Size: 3 MB 网页链接
Passage Bio(PASG)03-01 05:15
$Passage Bio(PASG)$ 8-K Current report, item 8.01 Accession Number: 0001104659-24-029361 Act: 34 Size: 201 KB 网页链接
Passage Bio(PASG)02-14 08:45
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-003637 Size: 15 KB 网页链接
Passage Bio(PASG)03-04 20:05
$Passage Bio(PASG)$ 8-K Current report, items 2.02, 5.02, 7.01, and 9.01 Accession Number: 0001558370-24-002309 Act: 34 Size: 6 MB 网页链接
Passage Bio(PASG)03-20 04:15
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008489 Size: 5 KB 网页链接
Passage Bio(PASG)03-20 04:15
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008491 Size: 5 KB 网页链接
Passage Bio(PASG)04-13 05:45
$Passage Bio(PASG)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000947871-24-000373 Act: 34 Size: 114 KB 网页链接
Passage Bio(PASG)04-17 18:05
$Passage Bio(PASG)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000982 Act: 33 Size: 1 KB 网页链接
Passage Bio(PASG)04-09 18:05
$Passage Bio(PASG)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-044915 Act: 34 Size: 1 MB 网页链接
Replix锐璞美股2021-04-05 19:19
$Passage Bio(PASG)$ Passage Bio Receives European Commission Orphan Designation for PBKR03 for Treatment of Krabbe Disease
$Moderna(MRNA)$ $百济神州(BGNE)$查看全文
Replix锐璞美股2021-03-03 20:20
$Passage Bio(PASG)$ $PASG$ Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
- On track to initiate three Phase 1/2 clinical programs in the first half of 2021: PBGM01 for GM1 gangliosidosis (GM1), PBFT02 for frontotemporal dementi...查看全文
神圣的升值毁灭者2021-01-29 02:33
$Passage Bio(PASG)$ FDA批准了Passage Bio's（PASG-0.9％）PBFT02的网页链接查看全文
神圣的升值毁灭者2021-01-22 21:26
$Passage Bio(PASG)$ 增发7M，22$查看全文
医药魔方2021-01-21 21:41
2020年1月，基因疗法开发商Generation Bio完成了1.1亿美元的C轮融资用以推进其A型血友病和苯丙酮尿症治疗药物的开发；5个月后，Generation又进行了首次公开募股（IPO），募资2.3亿美元。这无疑是一个迹象，表明投资者对下一代治疗罕见疾病的基因疗法非常感兴趣。
去年一年，尽管面临着各种挑战...查看全文
Replix锐璞美股2020-08-29 13:01
$Iovance(IOVA)$ 看看未来会发生什么。$Passage Bio(PASG)$ $CRISPR Therapeutics(CRSP)$查看全文
chuminhua2020-05-08 16:18
5/7，Passage Bio$Passage Bio(PASG)$ 与美国宾夕法尼亚大学去年达成合作，获得5款基因疗法，以及7个基因疗法的选择权。现在两家公司扩展了合作，增加了5个新项目，总计达到17个。合作期限也从2022年延长至2025年。作为回报，每年将向该大学提供500万美元。查看全文
医药魔方2020-03-01 16:40
chuminhua2020-02-28 23:21
2/27，Passage Bio$Passage Bio(PASG)$ 在Nasdaq IPO，发行价为18美元，共募集了2.16亿美元，比最初计划多72%。该公司聚焦基因疗法，与Frazier和OrbiMed合作，致力于开发罕见CNS单基因疾病的疗法。交易代码为$ PASG。查看全文
$Passage Bio(PASG)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000982 Act: 33 Size: 1 KB 网页链接
$Passage Bio(PASG)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000947871-24-000373 Act: 34 Size: 114 KB 网页链接
$Passage Bio(PASG)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-045039 Act: 34 Size: 848 KB 网页链接
$Passage Bio(PASG)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-044912 Act: 34 Size: 3 MB 网页链接
$Passage Bio(PASG)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-044915 Act: 34 Size: 1 MB 网页链接
$Passage Bio(PASG)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-002687 Act: 34 Size: 65 KB 网页链接
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008487 Size: 5 KB 网页链接
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008489 Size: 5 KB 网页链接
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008491 Size: 5 KB 网页链接
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008495 Size: 5 KB 网页链接